☆ 4.7 Editorial Material

ASO Author Reflections: Is it Correct to Use 5% Dextrose Solution as a Carrier Fluid for Oxaliplatin-based HIPEC?

ANNALS OF SURGICAL ONCOLOGY (2022)

Related references

Note: Only part of the references are listed.
Article Oncology

Pharmacologic Effects of Oxaliplatin Instability in Chloride-Containing Carrier Fluids on the Hyperthermic Intraperitoneal Chemotherapy to Treat Colorectal Cancer In Vitro and In Vivo

Eun Jung Park et al.

Summary: This study evaluated the degradation of oxaliplatin in carrier fluids with different chloride ion concentrations and identified the optimal carrier fluid for oxaliplatin-based HIPEC. Chloride-containing carrier fluids (such as normal saline or Dianeal) showed higher absorption rates of oxaliplatin and acceptable degradation rates.

ANNALS OF SURGICAL ONCOLOGY (2022)

Add to Collection
Article Oncology

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial

Francois Quenet et al.

Summary: This study aimed to evaluate the specific benefit of adding hyperthermic intraperitoneal chemotherapy (HIPEC) to cytoreductive surgery compared with receiving cytoreductive surgery alone in patients with colorectal peritoneal metastases. The results showed no significant overall survival benefit after adding HIPEC, with more frequent postoperative late complications, suggesting that cytoreductive surgery alone should be prioritized as a treatment strategy.

LANCET ONCOLOGY (2021)

Add to Collection
Review Gastroenterology & Hepatology

Treatment for Peritoneal Metastasis of Patients With Colorectal Cancer

Young Jin Kim et al.

Summary: Colorectal cancer peritoneal metastasis (CRC-PM) is found in 8% to 15% of patients with CRC and has a poor prognosis. Cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) significantly improves overall survival in selected patients. Management of CRC-PM should be carried out by experienced multidisciplinary teams in specialized centers.

ANNALS OF COLOPROCTOLOGY (2021)

Add to Collection
Article Gastroenterology & Hepatology

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy With Mitomycin C Used for Colorectal Peritoneal Carcinomatosis

Seung Jae Roh et al.

ANNALS OF COLOPROCTOLOGY (2020)

Add to Collection
Article Oncology

Cytoreductive Surgery Combined with Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin Increases the Risk of Postoperative Hemorrhagic Complications: Analysis of Predictive Factors

Thibaut Charrier et al.

ANNALS OF SURGICAL ONCOLOGY (2016)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.